Acute Visual Loss Induced by Dexamethasone During Neoadjuvant Docetaxol
2008
Visual Loss from Dexamethasone During Chemotherapy
Sample size: 1
publication
Evidence: low
Author Information
Author(s): Gregory D.L., Jones C.D., Denton E.R.E., Harnett A.N.
Primary Institution: Addenbrookes Hospital, Cambridge, UK
Hypothesis
Can steroid premedication during chemotherapy lead to central serous retinopathy?
Conclusion
The patient developed central serous retinopathy due to steroid treatment, which was resolved by reducing the steroid dosage.
Supporting Evidence
- The patient developed acute visual loss after receiving dexamethasone.
- Central serous retinopathy is a known side effect of steroids.
- Reducing the steroid dose allowed the patient to complete chemotherapy.
Takeaway
A woman lost her vision because of a medicine she took during cancer treatment, but she got better when the doctors changed her medicine.
Methodology
Case report detailing the patient's history, treatment, and outcomes.
Limitations
Only one case is reported, limiting generalizability.
Participant Demographics
42-year-old female with a history of breast cancer.
Want to read the original?
Access the complete publication on the publisher's website